Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT04783415 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04783415
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2022-07-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.